Palpable purpura (mandatory criterion) in the presence of at least one of the following four features: Diffuse abdominal pain; any biopsy showing predominant IgA deposition; arthritis (acute, any joint) or arthralgia; renal involvement (any hematuria and/or proteinuria). This evidence concerns the gene CD79A and arthritic joint disease.